What the study measured
Twelve healthy adults received oral melatonin alone and with caffeine in a pharmacokinetic study. Half were smokers. Serial blood samples measured exposure over several hours. [1]
Average peak melatonin concentration and total measured exposure increased with caffeine. The investigators proposed inhibition of CYP1A2 metabolism, with differences by smoking status and genotype. [1]
How far the finding goes
The study used a specific experimental schedule and measured blood concentrations, not a better night’s sleep. It does not show that the two substances simply cancel each other or provide a reliable combination regimen. Funding and conflicts were not established from the abstract. [1]
Higher exposure is not automatically greater benefit. Without measuring desired clinical outcomes and harms in an appropriate trial, the concentration finding cannot justify deliberately using caffeine to boost melatonin or adjusting a dose by the reported average change. [1]
A hypothetical distinction
Imagine a second substance slows removal of the first. The blood level can rise even when the substances have different perceived effects. That change alone does not reveal whether the combination is useful.
| Detail | Interpretation |
|---|---|
| 12 participants | Small exposure study |
| Blood concentrations | Higher with caffeine |
| Improved sleep | Not established |
Sources for this article
- Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity - PubMed
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.